Free Trial

Brokerages Set Owens & Minor, Inc. (NYSE:OMI) PT at $21.88

Owens & Minor logo with Medical background

Shares of Owens & Minor, Inc. (NYSE:OMI - Get Free Report) have been assigned an average recommendation of "Reduce" from the nine analysts that are currently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and one has given a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $21.88.

Several equities research analysts have recently issued reports on OMI shares. Citigroup raised their target price on shares of Owens & Minor from $24.00 to $28.00 and gave the stock a "neutral" rating in a report on Tuesday, April 30th. Robert W. Baird lowered their target price on shares of Owens & Minor from $24.00 to $20.00 and set a "neutral" rating for the company in a report on Tuesday. Bank of America lowered their target price on shares of Owens & Minor from $18.00 to $16.00 and set an "underperform" rating for the company in a report on Tuesday. StockNews.com lowered shares of Owens & Minor from a "buy" rating to a "hold" rating in a report on Thursday, May 23rd. Finally, TheStreet upgraded shares of Owens & Minor from a "d+" rating to a "c-" rating in a report on Monday, March 4th.

View Our Latest Report on Owens & Minor


Insider Activity at Owens & Minor

In related news, EVP Heath H. Galloway sold 2,031 shares of Owens & Minor stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $20.18, for a total transaction of $40,985.58. Following the completion of the sale, the executive vice president now owns 56,898 shares in the company, valued at approximately $1,148,201.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, EVP Heath H. Galloway sold 2,031 shares of the business's stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $20.18, for a total value of $40,985.58. Following the completion of the sale, the executive vice president now owns 56,898 shares in the company, valued at approximately $1,148,201.64. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Jonathan A. Leon sold 5,000 shares of the business's stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $24.84, for a total transaction of $124,200.00. Following the completion of the sale, the senior vice president now owns 84,673 shares of the company's stock, valued at approximately $2,103,277.32. The disclosure for this sale can be found here. Insiders sold 36,923 shares of company stock worth $686,911 in the last 90 days. 3.59% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the company. Riverview Trust Co purchased a new position in shares of Owens & Minor in the 1st quarter worth approximately $25,000. Hexagon Capital Partners LLC grew its position in shares of Owens & Minor by 1,240.2% in the 1st quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company's stock worth $43,000 after buying an additional 1,451 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Owens & Minor by 52.1% in the 1st quarter. GAMMA Investing LLC now owns 1,644 shares of the company's stock worth $46,000 after buying an additional 563 shares during the last quarter. Quest Partners LLC purchased a new position in shares of Owens & Minor in the 4th quarter worth approximately $41,000. Finally, Quarry LP grew its position in shares of Owens & Minor by 38.8% in the 4th quarter. Quarry LP now owns 2,573 shares of the company's stock worth $50,000 after buying an additional 719 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company's stock.

Owens & Minor Price Performance

Shares of NYSE:OMI traded down $0.24 on Friday, reaching $13.50. The company's stock had a trading volume of 2,003,594 shares, compared to its average volume of 965,078. Owens & Minor has a 52-week low of $13.26 and a 52-week high of $28.35. The company has a market cap of $1.03 billion, a P/E ratio of -26.47, a PEG ratio of 0.44 and a beta of 0.33. The company has a 50-day simple moving average of $18.71 and a 200 day simple moving average of $21.23. The company has a debt-to-equity ratio of 2.17, a quick ratio of 0.56 and a current ratio of 1.16.

Owens & Minor (NYSE:OMI - Get Free Report) last issued its quarterly earnings data on Friday, May 3rd. The company reported $0.19 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.02. Owens & Minor had a negative net margin of 0.37% and a positive return on equity of 12.97%. The business had revenue of $2.61 billion during the quarter, compared to analysts' expectations of $2.61 billion. During the same period last year, the company posted $0.05 EPS. The business's revenue was up 3.6% on a year-over-year basis. As a group, equities research analysts anticipate that Owens & Minor will post 1.53 EPS for the current fiscal year.

About Owens & Minor

(Get Free Report

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

See Also

Analyst Recommendations for Owens & Minor (NYSE:OMI)

Should you invest $1,000 in Owens & Minor right now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Dividend Traps: How to Identify and Avoid Them
52-Week Highs Explained: Boost Your Trades
Volkswagen’s $5 Billion Deal: Rivian Stock’s Real Boost or Just a Bailout?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines